Figures
Abstract
Background
Osteoporosis a common bone disorder characterized by decreases in bone mass, tension, and strength. Although many previous studies worldwide have sought to identify the risk factors for osteoporosis, studies that simultaneously examine a variety of factors, such as biochemical, anthropometric and nutritional components, are very rare. Therefore, the objective of this study was to simultaneously examine the association of osteoporosis with biochemical profiles, anthropometric factors, and nutritional components in a large-scale cross-sectional study.
Method
This cross-sectional study was based on data from the Korea National Health and Nutrition Examination Survey (KNHANES VI-VII) from 2015 to 2018. Based on data from 16,454 participants, logistic regression was used to examine the association between various parameters in a crude analysis and in models adjusted for confounders.
Results
In men, osteoporosis was significantly associated with the anthropometric variables height and weight; the biochemical components hemoglobin, hematocrit, urea nitrogen and urine pH and creatinine; and the nutritional components total food intake, energy, water, protein, phosphorus, and kalium. However, these associations disappeared in adjusted model 2. In women, osteoporosis was significantly related to the anthropometric measures height, weight, and systolic blood pressure; the biochemical components hemoglobin, hematocrit and urine pH; and the nutritional components total food intake, water, calcium, phosphorus, and kalium. Most of these associations were maintained in the adjusted models.
Citation: Yoo J, Lee BJ (2021) Anthropometric, biochemical, and nutritional risk factors for osteoporosis in Korean adults based on a large cross-sectional study. PLoS ONE 16(12): e0261361. https://doi.org/10.1371/journal.pone.0261361
Editor: Xiao-Feng Yang, Temple University School of Medicine, UNITED STATES
Received: May 6, 2021; Accepted: November 25, 2021; Published: December 13, 2021
Copyright: © 2021 Yoo, Lee. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The data used in this study are available from the 2015-2018 Korea National Health and Nutrition Examination Survey (KNHANES VI-VII) conducted by the Korea Centers for Disease Control and Prevention (KCDCP) and are freely available from the KCDCP (https://knhanes.kdca.go.kr/knhanes/main.do).
Funding: This work was supported by a Grant from the Korea Institute of Oriental Medicine (KIOM), funded by the Korean Government (KSN2013110). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Osteoporosis is a major public health problem related to fragility fractures that leads to morbidity, mortality, chronic pain, disability, and low quality of life [1–3]. Due to the aging of the world population, the prevalence of osteoporosis has increased rapidly [3–7]. The US Preventive Services Task Force estimated that approximately 12.3 million elderly Americans will have osteoporosis in 2020 [1]. In the European Union, approximately 3.79 million people have osteoporotic fractures; the health care costs of osteoporotic fractures were estimated at €32 billion in 2000, and the costs are expected to double by 2050 [2]. A total of 49 million people in Australia, Europe, North America, and Japan meet the World Health Organization criteria for osteoporosis. In mainland China, the standardized prevalence of osteoporosis in elderly men and women was estimated to range from 5.04% to 7.46% in 1990 and to reach 26.28% to 39.19% by 2050 [8].
Osteoporosis-related fractures occur in one in five adult men and one in three adult women during their lifetime after the age of 50 years in Western countries [9]. Osteoporosis is associated with bone mass loss and deterioration of the microarchitecture of the bone and is caused by fragility fractures, which are related to severe pain, reduced social function, and decreased physical function [10]. For the treatment for osteoporosis and therapeutic management, rehabilitation management focuses on improving quality of life and includes strategies such as pain reduction, increased physical function, and independence of daily activities [11, 12]. For example, some studies reported that occupational training and gradual strength training after surgery [11, 13, 14] and long-term care and management of patients through a health education program at home [11, 15] were effective for managing osteoporosis. In addition, patients with postmenopausal osteoporosis were prescribed drugs such as generic bisphosphonates to reduce the risk of spine and hip fractures [9, 16], and drugs such as teriparatide and abaloparatide are known to be very effective in enhancing hip and spine bone mineral density [9, 17]. Osteoporosis is diagnosed using bone mineral density (BMD), which is determined by dual energy X-ray absorptiometry (DXA or DEXA) of the lumbar spine and hip [2–4].
Risk factors for osteoporosis are generally very diverse. Risk factors may arise from medical treatment, such as glucocorticoid treatment [5, 18, 19]; diseases and medication use [3, 4, 20–23]; biochemical factors, such as hemoglobin [20, 24], total cholesterol, high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol LDL-C [14]; nutritional factors, such as the intake of calcium [4, 5, 7, 18, 22, 25–28] and vitamin D [4, 5, 7, 22, 26, 28–30]; sociodemographic or economic characteristics, such as age [2, 4, 5, 18, 20, 26, 30], female sex [4, 20, 26], education level [7], body size [2, 4–7, 22, 26] and body mass index (BMI) [3, 7, 18, 20, 27, 30]; menopause or premature menopause [4, 7, 22, 30]; behavior and habits, such as exercise or activity levels [3, 4, 18, 26, 30]; smoking [3–5, 18, 22, 26, 28, 31]; alcohol consumption [3, 4, 20, 26, 27, 30, 32]; and genetic factors, such as race or ethnicity [3–5, 22]. Some studies have suggested that osteoporosis is caused by a combination of these risk factors [5].
Although many previous studies worldwide have examined the risk factors for osteoporosis, studies that simultaneously investigate a variety of anthropometric, biochemical, and nutritional risk factors in the same subjects are very rare. Therefore, the objective of this study was to simultaneously examine the association of osteoporosis with biochemical profiles, anthropometric factors, and nutritional components in a large-scale cross-sectional study. Our findings and results will be useful for the treatment and prevention of osteoporosis in public health or epidemiological contexts.
Materials and methods
Subjects and data source
This study was based on data from the Korea National Health and Nutrition Examination Survey (KNHANES). The KNHANES is a nationally representative cross-sectional survey that has been conducted by the Korea Centers for Disease Control and Prevention (KCDC) since 2007 to examine the health and nutritional status of Koreans [33–35]. The participants are selected using a stratified, multistage probability sampling method to select household units from each survey section. The data from the Korea National Health and Nutrition Examination Survey are based on health examinations, nutrition surveys and health-related interviews with participants enrolled from 16 representative cities in the Republic of Korea. The KNHANES VI and VII collected data in 17 cities and provinces (Gyeonggi-do, Gangwon-do, Jeollabuk-do, Jeollanam-do, Chungcheongbuk-do, Chungcheongnam-do, Gyeongsangbuk-do, Gyeongsangnam-do, Jeju island, Seoul, Busan, Sejong, Daejeon, Daegu, Gwangju, Incheon, and Ulsan). Well-trained experts visited the homes of the subjects and conducted face-to-face health interviews on medical conditions using a questionnaire according to a rigorous process and protocol [33–37].
We used KNHANES VI and VII data from 2015 to 2018, which collected data regarding the diagnosis of osteoporosis. In KNHANES VI (2015) and VII (2016–2018), 31,649 individuals (14,452 men 17,197 women) participated. We limited our analyses to subjects older than 19 years. We excluded subjects with missing data on key covariates, including osteoporosis, covariates, blood samples, urine tests and dietary intake. The detailed sample selection procedure is shown in Fig 1.
For KNHANES VI and VII, 30 expert committees (comprising over 120 nominated experts in Korea) technically supported KNHANES for the validation and implementation of the survey. Only the survey staff members who passed intensive training course conducted the survey, and the staff members are trained frequently throughout the year to reinforce the appropriate techniques and protocol. All subjects should answer each question item about socioeconomic status and medical conditions through a self-administered questionnaire conducted by face-to-face interviews with well-trained staff members [33–37]. In addition, information on daily dietary intake based on the Korean Foods and Nutrients Database of the Rural Development Administration was collected [36]. More detailed information on the questionnaire and KNHANES survey has been provided previously [33–35].
The Institutional Review Board of the KCDC approved KNHANES VI and VII (2018-01-03-P-A), and the study was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from the participants. This study was performed at Korea Institute of Oriental Medicine (KIOM) and approved by the Institutional Review Board of KIOM (IRB No. I-2007/006-003).
Definition
In this study, the normal and osteoporosis groups were distinguished by whether subjects were diagnosed by a physician. Subjects with osteoporosis were identified by the question “Have you ever been diagnosed with osteoporosis by a physician?” in face-to-face interviews. All subjects answered “Yes”, “No”, or “Not applicable” based on the KCDC guidelines [33–35]. The osteoporosis group included subjects who answered “Yes”, and the normal group consisted of subjects who answered “No”. Those who answered “Not applicable” were excluded because they were adolescents or children [33–35].
Measurements
Anthropometric measures, biochemical profiles, and dietary intake (nutritional components) were used to investigate the association between osteoporosis and risk factors. Anthropometric measures were tested according to standardized protocols [33–35]. Blood samples were collected after more than 8 h of fasting. Fasting blood glucose, glycated hemoglobin (HbA1c), total cholesterol, triglycerides, aspartate transaminase (AST), alanine transaminase (ALT), hepatitis C virus antibody, hemoglobin, hematocrit, blood urea nitrogen, and blood creatinine were measured. Urine pH, specific gravity, and creatinine were assessed. Total food intake (g), energy (kcal), water (g), protein (g), total dietary fiber (g), calcium (mg), phosphorus (mg), iron (mg), kalium (mg), vitamin A (mg), and vitamin C (mg) were assessed in our study. Detailed measurements of all variables are presented in Table 1.
Covariates
As potential confounders, the following socioeconomic status and demographic variables were included: age, annual income, education, occupation, marital status, drinking, smoking, BMI and childbirth experience (women only). Education level was categorized into four groups: Below elementary, middle school graduate, high school graduate, and college graduate and above. Occupation types were classified into seven groups: 1) managers and professionals; 2) clerical support workers; 3) service and sales workers; 4) skilled agricultural, forestry and fishery workers; 5) craft, plant, or machine operators and assemblers; 6) laborers; and 7) unemployed (including students and homemakers). Marital status was divided into three groups: never married, currently married, and previously married. Smoking status was defined as current smoker, previously smoked, and never smoked. Alcohol consumption over the past 12 months was classified into two groups: no and yes.
Statistical analysis
Chi-square tests and t-tests were used to compare the prevalence of osteoporosis across covariates in the study population. To examine whether osteoporosis was related to each variable after standardization, we used univariable logistic regression in crude analysis and multiple logistic regression in adjusted models. In multiple logistic regression, models 1 and 2 each included one variable and covariates for adjustment. In men, model 1 was adjusted for age and BMI. Model 2 was adjusted for the variables in model 1 plus annual income, education, occupation, marital status, smoking, and drinking. In women, model 1 was adjusted for age and BMI. Model 2 was adjusted for the variables in model 1 plus annual income, education, occupation, marital status, smoking, drinking, and childbirth experience. Odds ratios were estimated with 95% confidence intervals. All statistical analyses were performed by using R version 3.6.2. To determine the reliability of the statistical results of the R program, we tested the results in a logistic regression with IBM SPSS version 23.
Results
A total of 16,454 subjects (6,802 men and 9,652 women) were included in the analysis. The numbers of normal and osteoporosis subjects were 6719 (98.8%) and 83 (1.2%) men and 8298 (86.0%) and 1354 (14.0%) women, respectively.
The characteristics of the study population are shown in Table 2. The prevalence of physician-diagnosed osteoporosis was 1.2% for men and 14.0% for women. The prevalence of osteoporosis was higher among older adults; those in the lower income group; those with less than an elementary education; skilled agricultural and forestry and fishery workers; previously married adults; nondrinkers; never-smokers; and women who had experienced childbirth.
Table 3 presents the association of osteoporosis with anthropometric, biochemical, and dietary factors in men. Among the anthropometric measures, the osteoporosis group was older than the normal group (OR = 1.08 [1.06–1.10]) and had a lower BMI (OR = 0.91 [0.85–0.98]). The osteoporosis group was more likely to be shorter (OR = 0.91 [0.88–0.93] in the crude model, adj. OR = 0.96 [0.93–1.00] in model 1) and weigh less (OR = 0.94 [0.92–0.96] in the crude model, adj. OR = 0.95 [0.91–1.00] in model 1). The association of systolic blood pressure (SBP) (OR = 1.02 [1.01–1.04]) and diastolic blood pressure (OR = 0.97 [0.95–0.99]) with osteoporosis was statistically significant in the crude model, but the statistical significance disappeared in models 1 and 2.
Regarding biochemical factors, osteoporosis was statistically significantly associated with alanine transaminase levels (OR = 0.70 [0.48–0.96]), hemoglobin levels (OR = 0.63 [0.54–0.75]), urine pH (OR = 1.27 [1.03–1.55]), and urine creatinine levels (OR = 0.59 [0.44–0.76]) in the crude model, but these associations were not statistically significant in models 1 and 2.
Among dietary factors, the osteoporosis group was more likely to have a lower total food intake (OR = 0.53 [0.39–0.70]) and lower intake of energy (OR = 0.61 [0.45–0.80]), water (OR = 0.60 [0.44–0.80]), protein (OR = 0.50 [0.35, 0.71], phosphorus (OR = 0.63 [0.46–0.83]) and kalium (OR = 0.73 [0.56–0.94]) in the crude model. However, the associations of dietary factors with osteoporosis became nonsignificant in model 1 and model 2.
Table 4 shows the association of osteoporosis with anthropometric, biochemical, and dietary factors in women. Age (OR = 1.11 [1.11–1.12]) and BMI (OR = 1.04 [1.02–1.05]) were statistically significantly related to osteoporosis. In all models, the osteoporosis group was more likely to be shorter (OR = 0.87 [0.86–0.88] in the crude model, adj. OR = 0.98 [0.97–0.99] in model 1, adj. OR = 0.99 [0.97–1.00] in model 2) and weigh less (OR = 0.97 [0.96–0.97] in the crude model, adj. OR = 0.97 [0.96–0.99] in model 1, adj. OR = 0.98 [0.96–1.00] in model 2). SBP was associated with osteoporosis (adj. OR = 0.99 [0.99–1.00] in model 1 and 2).
Regarding the biochemical factors, women with osteoporosis tended to have higher aspartate transaminase levels (OR = 1.25 [1.18–1.31] in the crude model, adj. OR = 1.07 [1.01–1.13] in model 1) and alanine transaminase levels (OR = 1.12 [1.07–1.17] in the crude model, adj. OR = 1.07 [1.00–1.14] in model 1) than women without osteoporosis. These associations were not statistically significant in model 2. Additionally, women in the osteoporosis group were more likely to have higher hemoglobin levels (adj. OR = 1.09 [1.02–1.17] in model 1, adj. OR = 1.08 [1.01–1.16] in model 2) and hematocrit levels (adj. OR = 1.09 [1.02–1.16] in model 1, adj. OR = 1.09 [1.02–1.16] in model 2). Urine pH was statistically significantly associated with osteoporosis in all models (OR = 1.24 [1.17–1.31] in the crude model, adj. OR = 1.14 [1.07–1.22] in model 1, adj. OR = 1.14 [1.07–1.21] in model 2).
Regarding dietary intake, osteoporosis was significantly associated with total food intake (adj. OR = 1.10 [1.02–1.18] in model 2) and with the intake of water (adj. OR = 1.10 [1.02–1.18] in model 2), total dietary fiber (adj. OR = 1.08 [1.01–1.15] in model 2), calcium (adj. OR = 1.10 [1.03–1.18] in model 2), phosphorus (adj. OR = 1.10 [1.02–1.18] in model 2), kalium (adj. OR = 1.07 [1.01–1.15] in model 2), and vitamin C (adj. OR = 1.06 [1.00–1.13] in model 2).
Discussion
Osteoporosis is a skeletal disorder that results in an increase in fractures of the spine, hip, and other bones [5], and osteoporosis and fragility fractures are among the most important causes of disability [1–3]. In summary, the risk factors for osteoporosis are known to arise from various risk factors, including biochemical profile [20, 23, 24], sociodemographic or economic characteristics [2–7, 18, 20, 22, 26, 30], behavior or activity [3–5, 18, 20, 22, 26–28, 30–32], nutritional intake [4, 5, 7, 18, 22, 25–30], genetics [3–5, 22], and disease, treatments or medications [3–5, 18–23].
Previous studies have presented conflicting arguments regarding whether biochemical factors are associated with osteoporosis. For example, Lian et al. [23] reported that hypertension, coronary heart disease, hyperlipidemia, diabetes, and smoking were significantly related to osteoporosis in elderly men and women in China. They argued that total cholesterol and LDL-C were risk factors for osteoporosis and that HDL-C and weight were protective factors against osteoporosis. Asaoka et al. [20] investigated the association of osteoporosis with several sociodemographic characteristics and Helicobacter pylori positivity in Japanese men and women and suggested that increasing age, female sex, lower alcohol consumption, lower BMI, lower hemoglobin, and Helicobacter pylori positivity were risk factors for osteoporosis, but diabetes and hypertension were not associated with osteoporosis. Yoon et al. [24] examined the association of BMD in the lumbar spine and femoral neck with red blood cells, hemoglobin, and hematocrit in Korean university students and argued that lower hemoglobin levels were linked to lower BMD and that hemoglobin levels were the best indicator of abnormal BMD. In contrast, Sánchez-Rodríguez et al. [38] reported that glucose, urea, creatinine, urate, cholesterol, triglycerides, HDL-C, albumin, hemoglobin, and hematocrit were not associated with osteoporosis in elderly Mexican adults. Our findings were consistent with the results of previous studies indicating that hemoglobin was associated with osteoporosis [20, 24] and that cholesterol, glucose, creatinine, and triglycerides were not [38]. Our results showed that hemoglobin levels were related to osteoporosis in women, but cholesterol, glucose, creatinine, and triglycerides were not associated with osteoporosis in either men or women in adjusted models.
Regarding nutritional components, for example, Woo et al. [39] argued that SBP and dietary calcium intake were associated with bone mineral density and osteoporosis in elderly men and women in Hong Kong. Ilesanmi-Oyelere and Kruger [40] suggested that phosphorus, calcium, fiber, potassium, magnesium, and vitamin D and K were important for BMD based on a literature review on postmenopausal osteoporosis. Another study by Ilesanmi-Oyelere et al. [41] argued that calcium, niacin, protein, and riboflavin intake was associated with spine BMD and high phosphorus, calcium, and riboflavin intake was positively associated with femoral neck and spine BMD. Collier et al. [30] argued that vitamin D deficiency was associated with bone turnover, bone loss, and osteoporosis. Kim et al. [42] documented that dietary food intake was associated with osteoporosis in elderly Koreans, and vitamin B2 or vitamin C was related to the disease. Kim et al. [43] argued that the intake of vitamin C, sodium, and zinc was positively related to bone mass or T-scores in postmenopausal Korean women. Lane [5] reported that risk factors for osteoporosis were smoking, small body size, low bone mass, low physical activity, ethnicity, history of fractures, and low intake of vitamin D and calcium. Holm et al. [18] documented that high BMI, old age, smoking, high amounts of exercise, hyperthyroidism, use of thiazide diuretics, previous osteoporosis treatment and osteoporotic fracture, and calcium supplementation intake were indicators of osteoporosis in women. Aloia et al. [28] reported that smoking was associated with a high risk of osteoporosis, and sufficient intake of vitamin D and calcium was associated with a low risk of osteoporosis in postmenopausal women. Furthermore, Gimigliano et al. [44] examined associations among vitamin D, fat mass, and skeletal muscle and the effects of the combination of obesity and hypovitaminosis D in postmenopausal women. They reported that hypovitaminosis D was related to impaired muscle function and that the combination of hypovitaminosis D and overweight elicited a negative effect on muscle mass and function. Also, Ringe [45] argued that alfacalcidol had shown efficacy in the treatment and prevention of osteoporosis and fractures related to osteoporosis both in monotherapy and combined therapy with other osteoporotic drugs in postmenopausal women and men with osteoporosis. Keramat et al. [7] argued that lower education level, BMI, age at menopause, age at menarche, calcium supplementation, and history of fracture were significantly associated with the risk of osteoporosis in postmenopausal women in Iran and India. They documented that high weight and BMI were protective factors, and short stature was a risk factor for osteoporosis. Our findings agree with the results of previous studies [5, 7, 18, 28, 40, 41] indicating that calcium and/or phosphorus were related to osteoporosis in women. However, our results were different from those of a previous study [39]. Our results indicated that osteoporosis was associated with calcium only in women and not in men.
In addition to anthropometric factors and sociodemographic and economic characteristics, numerous studies have argued that many variables related to obesity and sociodemographic characteristics are associated with osteoporosis. For example, in a systematic review of 34 guidelines based on the Appraisal of Guidelines for Research and Evaluation instrument in terms of exercise, physical activity, or rehabilitation for osteoporosis therapy, Iolascon et al. [46] reported that therapeutic exercise or rehabilitation at moderate to high intensity was recommended for the management of subjects with fragility fractures and osteoporosis. Siris et al. [3] documented that aging, cigarette smoking, history of fracture, use of cortisone, and Hispanic or Asian ethnicity were related to a high risk of osteoporosis and that exercise, alcohol consumption, estrogen use, higher BMI, and African American ethnicity were associated with a low risk of osteoporosis. Collier et al. [30] mentioned that high alcohol consumption, low BMI, physical inactivity, previous fracture, and premature menopause were major independent risk factors for osteoporosis or osteoporotic fractures. Pouresmaeili et al. [26] documented that osteoporosis risk factors included weight loss, smoking, alcohol consumption, stress, insufficient physical activity and nutrition intake, aging, sex, and family history. Heidari et al. [47] reported that osteoporosis was associated with obesity and education level in postmenopausal women. Reginster and Burlet [2] argued that the strongest predictor of osteoporosis is older age and indicated that a history of hip fracture, low weight, and several diseases were associated with fractures. Assantachai et al. [6] reported that risk factors for osteoporosis in elderly Thai people were mental health, height, and lean body mass. Seeman et al. [27] reported that smoking, alcohol consumption, calcium levels and bone metabolism were associated with a high risk of osteoporosis, and obesity was protective against osteoporosis in men. Kanis [4] and Kanis and McCloskey [22] reported that female sex, age, premature menopause, White and Asian ethnicity, low bone mineral density, low weight, smoking, excessive drinking, inactivity, low calcium intake and insufficient vitamin D intake were risk factors for osteoporosis. Mangiafico et al. [48] reported that central aortic SBP was higher among postmenopausal women with osteoporosis than in those without osteoporosis. Our findings were consistent with those of previous studies indicating that BMI or obesity was linked to osteoporosis in women [2–4, 6, 22, 26, 30, 47] and men [6, 8].
Our study has several limitations. First, cause-effect relationships cannot be explained given the nature of cross-sectional studies. Second, we cannot guarantee that the findings of this study are comparable to those of studies conducted in other countries due to differences in socioeconomic characteristics and dietary and obesity criteria among ethnic groups. Third, our results may be affected by a number of biases including survey bias and self-reported diagnosis of osteoporosis. Fourth, our study did not consider the presence and assessment of fragility fractures in the osteoporosis subject group or the assessment of some covariates including physical activity or serum vitamin D levels. Finally, compared to the number of original samples in KNHANES, a large number of samples was excluded from the analysis.
In conclusion, we examined the association between osteoporosis and biochemical, anthropometric and nutritional components in a large-scale cross-sectional study. We found various risk factors for osteoporosis among anthropometric measures, blood and urine factors and nutritional components in Korean women. We hope that our findings and results will provide useful information for the treatment or prevention of osteoporosis in public health or epidemiology contexts.
References
- 1. Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. Screening for osteoporosis to prevent fractures: US Preventive Services Task Force recommendation statement. JAMA. 2018;319: 2521–2531. pmid:29946735
- 2. Reginster JY, Burlet N. Osteoporosis: a still increasing prevalence. Bone. 2006;38: 4–9. pmid:16139579
- 3. Siris ES, Miller PD, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA. 2001;286: 2815–2822. pmid:11735756
- 4. Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet. 2002;359: 1929–1936. pmid:12057569
- 5. Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol. 2006;194: S3–S11. pmid:16448873
- 6. Assantachai P, Angkamat W, Pongpim P, Weattayasuthum C, Komoltri C. Risk factors of osteoporosis in institutionalized older Thai people. Osteoporos Int. 2006;17: 1096–1102. pmid:16544053
- 7. Keramat A, Patwardhan B, Larijani B, Chopra A, Mithal A, Chakravarty D, et al. The assessment of osteoporosis risk factors in Iranian women compared with Indian women. BMC Musculoskelet Disord. 2008;9: 1–10. pmid:18182116
- 8. Cui Z, Meng X, Feng H, Zhuang S, Liu Z, Zhu T, et al. Estimation and projection about the standardized prevalence of osteoporosis in mainland China. Arch Osteoporos. 2020;15: 1–11.
- 9. Lorentzon M, Johansson H, Harvey NC, Liu E, Vandenput L, McCloskey EV, et al. Osteoporosis and fractures in women: the burden of disease. Climacteric. 2021;28: 1–7. pmid:34319208
- 10. Lips P, van Schoor NM. Quality of life in patients with osteoporosis. Osteoporos Int. 2005;16: 447–455. pmid:15609073
- 11. de Sire A, Invernizzi M, Baricich A, Lippi L, Ammendolia A, Grassi FA, et al. Optimization of transdisciplinary management of elderly with femur proximal extremity fracture: a patient-tailored plan from orthopaedics to rehabilitation. World J Orthop. 2021;12: 456–466. pmid:34354934
- 12. de Sire A, Ammendolia A, Gimigliano A, Tiberi R, Cisari C, Invernizzi M. Spinal orthoses prescription for vertebral fragility fractures by Italian physical and rehabilitation medicine physicians: the SPIN-VER survey. Healthcare (Basel). 2021;9: 892. pmid:34356276
- 13. Oldmeadow LB, Edwards ER, Kimmel LA, Kipen E, Robertson VJ, Bailey MJ. No rest for the wounded: early ambulation after hip surgery accelerates recovery. ANZ J Surg. 2006;76: 607–611. pmid:16813627
- 14. Overgaard J, Kristensen MT. Feasibility of progressive strength training shortly after hip fracture surgery. World J Orthop. 2013;4: 248–258. pmid:24147260
- 15. Lin PC, Lu CM. Psychosocial factors affecting hip fracture elder’s burden of care in Taiwan. Orthop Nurs. 2007;26: 155–161. pmid:17538469
- 16. Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007;356: 1809–1822. pmid:17476007
- 17. Miller PD, Hattersley G, Riis BJ, Williams GC, Lau E, Russo LA, et al. Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial. JAMA. 2016;316: 722–733. pmid:27533157
- 18. Holm JP, Hyldstrup L, Jensen JEB. Time trends in osteoporosis risk factor profiles: a comparative analysis of risk factors, comorbidities, and medications over twelve years. Endocrine. 2016;54: 241–255. pmid:27178283
- 19. Peel NF, Moore DJ, Barrington NA, Bax DE, Eastell R. Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis. 1995;54: 801–806. pmid:7492217
- 20. Asaoka D, Nagahara A, Shimada Y, Matsumoto K, Ueyama H, Matsumoto K, et al. Risk factors for osteoporosis in Japan: is it associated with Helicobacter pylori? Ther Clin Risk Manag. 2015;11: 381–391. pmid:25834453
- 21. Zhou R, Zhou H, Rui L, Xu J. Bone loss and osteoporosis are associated with conversion from mild cognitive impairment to Alzheimer’s disease. Curr Alzheimer Res. 2014;11: 706–713. pmid:25115539
- 22. Kanis JA, McCloskey EV. Risk factors in osteoporosis. Maturitas. 1998;30: 229–233.
- 23. Lian XL, Zhang YP, Li X, Jing LD, Cairang ZM, Gou JQ. Exploration on the relationship between the elderly osteoporosis and cardiovascular disease risk factors. Eur Rev Med Pharmacol Sci. 2017;21: 4386–4390. pmid:29077156
- 24. Yoon J, Kim DJ, Sung HH, Jo YK. Analysis of bone mineral density according to hemoglobin in university students. Korean J Clin Lab Sci. 2016;48: 296–303.
- 25. Nguyen TV, Center JR, Eisman JA. Osteoporosis in elderly men and women: effects of dietary calcium, physical activity, and body mass index. J Bone Miner Res. 2000;15: 322–331. pmid:10703935
- 26. Pouresmaeili F, Kamalidehghan B, Kamarehei M, Goh YM. A comprehensive overview on osteoporosis and its risk factors. Ther Clin Risk Manag. 2018;14: 2029–2049. pmid:30464484
- 27. Seeman E, Melton LJ, O’Fallon WM, Riggs BL. Risk factors for spinal osteoporosis in men. Am J Med. 1983;75: 977–983. pmid:6650552
- 28. Aloia JF, Cohn SH, Vaswani A, Yeh JK, Yuen K, Ellis K. Risk factors for postmenopausal osteoporosis. Am J Med. 1985;78: 95–100. pmid:3966495
- 29. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001;22: 477–501. pmid:11493580
- 30. Collier JD, Ninkovic M, Compston JE. Guidelines on the management of osteoporosis associated with chronic liver disease. Gut. 2002;50: i1–i9. pmid:11788576
- 31. Krall EA, Dawson‐Hughes B. Smoking increases bone loss and decreases intestinal calcium absorption. J Bone Miner Res. 1999;14: 215–220. pmid:9933475
- 32. Hannan MT, Felson DT, Dawson‐Hughes B, Tucker KL, Cupples LA, Wilson PWF, et al. Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res. 2000;15: 710–720. pmid:10780863
- 33.
Korea Centers for Disease Control and Prevention. Quality control of the clinical laboratory for the Korea National Health and Nutrition Examination Survey (KNHANES VII, 2016–2018). Korea: Korea Centers for Disease Control and Prevention; 2016.
- 34.
Korea Centers for Disease Control and Prevention. Guideline for the seventh Korea National Health and Nutrition Examination Survey (KNHANES VII, 2016–2018). Korea: Korea Centers for Disease Control and Prevention; 2016.
- 35. Kweon S, Kim Y, Jang MJ, Kim Y, Kim K, Choi S, et al. Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol. 2014;43: 69–77. pmid:24585853
- 36. Lee BJ, Kim J, Kim KH. Association of gastric and duodenal ulcers with anthropometry and nutrients: Korean National Health and Nutrition Examination Survey (KNHANES II-IV) 2001–2009. PLoS One. 2018;13: e0207373. pmid:30440018
- 37. Yim MH, Kim KH, Lee BJ. The number of household members as a risk factor for peptic ulcer disease. Sci Rep. 2021;11: 5274. pmid:33674696
- 38. Sánchez-Rodríguez MA, Ruiz-Ramos M, Correa-Muñoz E, Mendoza-Núñez VM. Oxidative stress as a risk factor for osteoporosis in elderly Mexicans as characterized by antioxidant enzymes. BMC Musculoskelet Disord. 2007;8: 1–7. pmid:17204151
- 39. Woo J, Kwok T, Leung J, Tang N. Dietary intake, blood pressure and osteoporosis. J Hum Hypertens. 2009;23: 451–455. pmid:19092844
- 40. Ilesanmi-Oyelere BL, Kruger MC. Nutrient and dietary patterns in relation to the pathogenesis of postmenopausal osteoporosis—a literature review. Life. 2020;10: 220. pmid:32992740
- 41. Ilesanmi-Oyelere BL, Brough L, Coad J, Roy N, Kruger MC. The relationship between nutrient patterns and bone mineral density in postmenopausal women. Nutrients. 2019;11: 1262. pmid:31163708
- 42. Kim MH, Lee JS, Johnson MA. Poor socioeconomic and nutritional status are associated with osteoporosis in Korean postmenopausal women: data from the Fourth Korea National Health and Nutrition Examination Survey (KNHANES) 2009. J Am Coll Nutr. 2015;34: 400–407. pmid:25826107
- 43. Kim DE, Cho SH, Park HM, Chang YK. Relationship between bone mineral density and dietary intake of β-carotene, vitamin C, zinc and vegetables in postmenopausal Korean women: a cross-sectional study. J Int Med Res. 2016;44: 1103–1114. pmid:27664069
- 44. Gimigliano F, Moretti A, de Sire A, Calafiore D, Iolascon G. The combination of vitamin D deficiency and overweight affects muscle mass and function in older post-menopausal women. Aging Clin Exp Res. 2018;30: 625–631. pmid:29488185
- 45. Ringe JD. Plain vitamin D or active vitamin D in the treatment of osteoporosis: where do we stand today? Arch Osteoporos. 2020;15: 182. pmid:33188611
- 46. Iolascon G, de Sire A, Curci C, Paoletta M, Liguori S, Calafiore D, et al. Osteoporosis guidelines from a rehabilitation perspective: systematic analysis and quality appraisal using AGREE II. Eur J Phys Rehabil Med. 2021;57: 273–279. pmid:33650841
- 47. Heidari B, Hosseini R, Javadian Y, Bijani A, Sateri MH, Nouroddini HG. Factors affecting bone mineral density in postmenopausal women. Arch Osteoporos. 2015;10: 1–7. pmid:25972061
- 48. Mangiafico RA, Alagona C, Pennisi P, Parisi N, Mangiafico M, Purrello F, et al. Increased augmentation index and central aortic blood pressure in osteoporotic postmenopausal women. Osteoporos Int. 2008;19: 49–56. pmid:17676381